Detalhe da pesquisa
1.
Novel BRD2::NUTM1 Fusion in NUT Carcinoma With Exceptional Response to Chemotherapy: A Case Report.
JTO Clin Res Rep
; 5(1): 100625, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287941
2.
Overexpressed Gα13 activates serum response factor through stoichiometric imbalance with Gßγ and mislocalization to the cytoplasm.
Cell Signal
; 102: 110534, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442589
3.
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
Cancer Res
; 83(23): 3846-3860, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819236
4.
EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes.
bioRxiv
; 2023 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645799
5.
EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes.
Cancer Res
; 83(23): 3956-3973, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37747726